Menko FH, ter Stege JA, van der Kolk LE, Jeanson KN, Schats W, Moha DA, et al. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Fam Cancer. 2019;18:127–35.
Human Genetics Society of Australasia: Process of Genetic Counselling. Sydney, 2008.
Forrest LE, Delatycki MB, Curnow L, Skene L, Aitken M. Genetic health professionals and the communication of genetic information in families: Practice during and after a genetic consultation. Am J Med Genet Part A. 2010;152A:1458–66.
Healey E, Taylor N, Greening S, Wakefield CE, Warwick L, Williams R, et al. Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families. Genet Med. 2017;19:1323–31.
Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. 2020;28:1631–44.
Courtney E, Chok AK-L, Ting Ang ZL, Shaw T, Li S-T, Yuen J, et al. Impact of free cancer predisposition cascade genetic testing on uptake in Singapore. npj Genom Med. 2019;4:22.
Roberts MC, Dotson WD, DeVore CS, Bednar EM, Bowen DJ, Ganiats TG, et al. Delivery of cascade screening for hereditary conditions: a scoping review of the literature. Health Aff. 2018;37:801–8.
George R, Kovak K, Cox SL. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. J Genet Counseling. 2015;24:388–99.
Hodgson JM, Metcalfe SA, Aitken M, Donath SM, Gaff CL, Winship IM, et al. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention. BMC Med Genet. 2014;15:33.
Gaff C, Hodgson J. A Genetic Counseling Intervention to Facilitate Family Communication About Inherited Conditions. J Genet Counseling. 2014;23:814–23.
Marleen van den Heuvel L, Stemkens D, van Zelst-Stams WAG, Willeboordse F, Christiaans I. How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population. J Genet Couns. 2020;29:786–99.
Frey MK, Ahsan MD, Bergeron H, Lin J, Li X, Fowlkes RK, et al. Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis. J Clin Oncol. 2022;40:4129–43.
Aktan-Collan K, Haukkala A, Pylvänäinen K, Järvinen HJ, Aaltonen LA, Peltomäki P, et al. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet. 2007;44:732–8.
Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E, et al. The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. Fam Cancer. 2016;15:155–62.
van den Heuvel LM, Hoedemaekers YM, Baas AF, Baars MJH, van Tintelen JP, Smets EMA, et al. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. Eur J Hum Genet. 2022;30:203–10.
Newson AJ: Why genetics services should contact at-risk relatives directly: Progress Educational Trust, 2006.
Marks D, Thorogood M, Neil SM. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes. J Med Screen. 2006;13:156–9.
Henrikson NB, Blasi P, Figueroa Gray M, Tiffany BT, Scrol A, Ralston JD, et al. Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening. J Personalized Med. 2021;11:538.
Dheensa S, Lucassen A, Fenwick A. Limitations and Pitfalls of Using Family Letters to Communicate Genetic Risk: a Qualitative Study with Patients and Healthcare Professionals. J Genet Counseling. 2018;27:689–701.
Evans D, Binchy A, Shenton A, Hopwood P, Craufurd D. Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin Genet. 2009;75:124–32.
van El CG, Baccolini V, Piko P, Cornel MC. Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia. Healthcare (Basel) 2018;6:108.
Louter L, Defesche J, Roeters van Lennep J. Cascade screening for familial hypercholesterolemia: Practical consequences. Atheroscler Suppl. 2017;30:77–85.
Galema-Boers JM, Versmissen J, Roeters van Lennep HW, Dusault-Wijkstra JE, Williams M, Roeters van Lennep JE. Cascade screening of familial hypercholesterolemia must go on. Atherosclerosis. 2015;242:415–7.
d’Audiffret Van Haecke D, de Montgolfier S. Genetic diseases and information to relatives: practical and ethical issues for professionals after introduction of a legal framework in France. Eur J Hum Genet. 2018;26:786–95.
Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet. 2006;43:665–70.
Maxwell S, Molster C, Poke S, O’leary P. Communicating Familial Hypercholesterolemia Genetic Information Within Families. Genet Test Mol Biomark. 2009;13:301–6.
Hardcastle SJ, Legge E, Laundy CS, Egan SJ, French R, Watts GF, et al. Patients’ Perceptions and Experiences of Familial Hypercholesterolemia, Cascade Genetic Screening and Treatment. Int J Behav Med. 2015;22:92–100.
Watts GF, Sullivan DR, Hare DL, Kostner KM, Horton AE, Bell DA, et al. Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart, Lung Circ. 2021;30:324–49.
Dynata web page. Available from https://www.dynata.com/ [accessed May 2023].
StataCorp: Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC, 2021.
Australian Bureau of Statistics: Snapshot of Australia: A picture of the economic, social and cultural make-up of Australia on Census Night, 10 August 2021., 2022.
Pentz RD, Peterson SK, Watts B, Vernon SW, Lynch PM, Koehly LM, et al. Hereditary Nonpolyposis Colorectal Cancer Family Members’ Perceptions about the Duty to Inform and Health Professionals’ Role in Disseminating Genetic Information. Genet Test. 2005;9:261–8.
Koehly LM, Peters JA, Kenen R, Hoskins LM, Ersig AL, Kuhn NR, et al. Characteristics of Health Information Gatherers, Disseminators, and Blockers Within Families at Risk of Hereditary Cancer: Implications for Family Health Communication Interventions. Am J Public Health. 2009;99:2203–9.
Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol. 2008;6:333–8.
Mendes Á, Metcalfe A, Paneque M, Sousa L, Clarke AJ, Sequeiros J. Communication of Information about Genetic Risks: Putting Families at the Center. Fam Process. 2018;57:836–46.
Dheensa S, Fenwick A, Shkedi-Rafid S, Crawford G, Lucassen A. Health-care professionals’ responsibility to patients’ relatives in genetic medicine: a systematic review and synthesis of empirical research. Genet Med: Off J Am Coll Med Genet. 2016;18:290–301.
Ho A, Leach E, Virani A, Arbour L, Bartels K, Wong EK. Cascade testing for inherited arrhythmia conditions: Experiences and attitudes of family communication approaches for a Canadian cohort. J Genet Counseling. 2022;31:815–28.
Andersson A, Hawranek C, Öfverholm A, Ehrencrona H, Grill K, Hajdarevic S, et al. Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden. Hereditary Cancer Clin Pract. 2020;18:18.
Ormondroyd E, Oates S, Parker M, Blair E, Watkins H. Pre-symptomatic genetic testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical implications. Eur J Hum Genet. 2014;22:88–93.
Campbell M, Humanki J, Zierhut H. A novel approach to screening for familial hypercholesterolemia in a large public venue. J Community Genet. 2017;8:35–44.
Stol YH, Menko FH, Westerman MJ. Janssens RMJPA: Informing family members about a hereditary predisposition to cancer: attitudes and practices among clinical geneticists. J Med Ethics. 2010;36:391–5.
Henrikson NB, Wagner JK, Hampel H, DeVore C, Shridhar N, Williams JL, et al. What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing? J Law Biosci. 2020;7:lsaa071.
Tiller J, Nowak K, Boughtwood T, Otlowski M. Privacy implications of contacting the at-risk relatives of patients with medically-actionable genetic predisposition, with patient consent: A hypothetical case study. BioTech. 2023;12:45.
Shahroz M, Ahmad F, Younis MS, Ahmad N, Kamel Boulos MN, Vinuesa R, et al. COVID-19 digital contact tracing applications and techniques: A review post initial deployments. Transp Eng. 2021;5:100072.
Tiller J, Winship I, Otlowski MF, Lacaze PA. Monitoring the genetic testing and life insurance moratorium in Australia: a national research project. Medical J Australia. 2021;214:157–9.e1.
Tiller J, Bakshi A, Dowling G, Keogh L, McInerney-Leo A, Barlow-Stewart K, et al. Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing. Eur J Hum Genet. 2023. https://doi.org/10.1038/s41431-023-01373-1. Online ahead of print.
Tiller J, Morris S, Rice T, Barter K, Riaz M, Keogh L, et al. Genetic discrimination by Australian insurance companies: a survey of consumer experiences. European J Human Genetics. 2019; 28,108–13
Tiller JM, Keogh LA, McInerney-Leo AM, Belcher A, Barlow-Stewart K, Boughtwood T, et al. A step forward, but still inadequate: Australian health professionals’ views on the genetics and life insurance moratorium. J Med Genet. 2021;59:817–26.
Dowling G, Tiller J, McInerney-Leo A, Belcher A, Haining C, Barlow-Stewart K et al. Health professionals’ views and experiences of the Australian moratorium on genetic testing and life insurance: A qualitative study. Eur J Hum Genet. 2022; 30:1262–68
Newson AJ, Humphries SE. Cascade testing in familial hypercholesterolaemia: how should family members be contacted? Eur J Hum Genet. 2005;13:401–8.
Grill K, Rosén A. Healthcare professionals’ responsibility for informing relatives at risk of hereditary disease. J Med Ethics. 2020;47:e12.